Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2007-06-04 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VILLE-D'AVRAY (92410), Hauts-de-Seine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
LES PHARMACIENS ASSOCIES : revenue, balance sheet and financial ratios
LES PHARMACIENS ASSOCIES is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VILLE-D'AVRAY (92410),
this company of category PME
shows in 2025 a net income positive of 114 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - LES PHARMACIENS ASSOCIES (SIREN 498314004)
Indicator
2025
2024
2023
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
113 520 €
75 813 €
83 278 €
90 566 €
90 643 €
86 511 €
102 976 €
75 616 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, LES PHARMACIENS ASSOCIES generates positive net income of 114 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 76 k€ -> 114 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
113 520 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 26%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 72%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
25.973%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
71.92%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution LES PHARMACIENS ASSOCIES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2023
2024
2025
Debt ratio
194.589
146.427
118.834
103.359
81.305
49.425
39.296
25.973
Financial autonomy
30.821
37.107
41.395
44.184
48.528
60.38
63.035
71.92
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
25.972025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good-7 pts over 3 years
In 2025, the debt ratio of LES PHARMACIENS ASSOCIES (25.97) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
71.92%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good+10 pts over 3 years
In 2025, the financial autonomy of LES PHARMACIENS ASSOCIES (71.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 289.57. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
289.568
Liquidity indicators evolution LES PHARMACIENS ASSOCIES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2023
2024
2025
Liquidity ratio
177.474
200.852
212.671
200.284
206.125
269.894
237.805
289.568
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
289.572025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent
In 2025, the liquidity ratio of LES PHARMACIENS ASSOCIES (289.57) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of LES PHARMACIENS ASSOCIES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of LES PHARMACIENS ASSOCIES is estimated at
1 803 278 €
(range 1 223 713€ - 2 829 592€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1223k€1803k€2829k€
1 803 278 €Range: 1 223 713€ - 2 829 592€
NAF 5 année 2025
Valuation method used
Net Income Multiple
113 520 €
×
15.9x
=1 803 279 €
Range: 1 223 713€ - 2 829 593€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare LES PHARMACIENS ASSOCIES with other companies in the same sector:
Frequently asked questions about LES PHARMACIENS ASSOCIES
What is the revenue of LES PHARMACIENS ASSOCIES ?
The revenue of LES PHARMACIENS ASSOCIES is not publicly disclosed (confidential accounts filed with INPI).
Is LES PHARMACIENS ASSOCIES profitable?
Yes, LES PHARMACIENS ASSOCIES generated a net profit of 114 k€ in 2025.
Where is the headquarters of LES PHARMACIENS ASSOCIES ?
The headquarters of LES PHARMACIENS ASSOCIES is located in VILLE-D'AVRAY (92410), in the department Hauts-de-Seine.
Where to find the tax return of LES PHARMACIENS ASSOCIES ?
The tax return of LES PHARMACIENS ASSOCIES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does LES PHARMACIENS ASSOCIES operate?
LES PHARMACIENS ASSOCIES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart